Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $0.97.

  • Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) fell 2049.18% to $0.97 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.79, marking a year-over-year decrease of 1124.12%. This contributed to the annual value of $4.29 for FY2025, which is 276.36% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported EPS (Weighted Average and Diluted) of $0.97 as of Q4 2025, which was down 2049.18% from $0.86 recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) ranged from a high of $1.22 in Q4 2024 and a low of -$4.79 during Q1 2023
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $1.01 (2022), whereas its average is $0.72.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) crashed by 56960.78% in 2023, and later soared by 12045.93% in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) stood at $0.99 in 2021, then rose by 5.05% to $1.04 in 2022, then increased by 1.92% to $1.06 in 2023, then grew by 15.09% to $1.22 in 2024, then fell by 20.49% to $0.97 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.97 in Q4 2025, compared to $0.86 in Q3 2025 and $0.95 in Q2 2025.